Banner for leaf pages 2

Bromfenac (Bromday)

Also known as Duract, Xibrom, and Bromday

Bromfenac is a non-steroidal anti-inflammatory drug (NSAID) marketed in the US as an ophthalmic solution (current brand name Bromday, prior formulation brand name Xibrom, which has since been discontinued.) by ISTA Pharmaceuticals for short-term, local use. Bromday® is the once-daily formulation of bromfenac, while Xibrom®, which has since been discontinued, was the twice-daily formulation. Bromfenac is indicated for the treatment of ocular inflammation and pain after cataract surgery, though it may be prescribed in an off-label manner by the physician.

Source: Wikipedia

Estimated Total Cost: $198.11 for an average of 28 days supply

What is it prescribed for?

Patients are most commonly prescribed bromfenac to treat diabetes, blastomycosis, rabies, and west nile virus.

What drug interactions are known?

Do not take bromfenac if you are taking any of the following:

Critical Interactions

Significant Interactions

Ajax-loader Loading...